Journal of Microencapsulation 2012-01-01

Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition on β-aescin encapsulation.

H Van de Ven, J Vandervoort, W Weyenberg, S Apers, A Ludwig

Index: J. Microencapsul. 29(2) , 115-25, (2012)

Full Text: HTML

Abstract

The objective of this study was to enhance the encapsulation of the antileishmanial saponin aescin in poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles (NPs). We prepared the NPs by the O/W and W/O/W combined emulsification solvent evaporation/salting-out technique and investigated the influence of organic phase composition on the NPs' size, zeta potential and entrapment efficiency (EE%) using mixture designs. The obtained NPs were monodispersed with Z(ave)<300 nm and exhibited negative zeta potentials. For the single emulsion, the co-solvent concentration was shown to be the primary determinant of drug entrapment. The EE% increased from 14% to 22% by decreasing the amount of DMSO from 80% to 25% (v/v) in the organic polymer solution. For the double emulsion, EE% was 22% on average and independent of the organic phase composition. The double-emulsion technique did not enhance the aescin encapsulation as expected due to its amphiphilic nature. The optimised aescin-loaded NPs meet the requirements for further in vitro activity tests.


Related Compounds

Related Articles:

Effect of beta-aescin extract from Chinese buckeye seed on chronic venous insufficiency.

2013-06-01

[Pharmazie 68(6) , 428-30, (2013)]

Interaction between titanium and cadmium in various guinea pig organs.

2013-02-01

[Biol. Trace Elem. Res. 151(2) , 209-16, (2013)]

Rho-kinase inhibition attenuates calcium-induced contraction in β-escin but not Triton X-100 permeabilized rabbit femoral artery.

2011-09-01

[J. Muscle Res. Cell Motil. 32(2) , 77-88, (2011)]

Bioavailability of l-thyroxine and its metabolites after topical treatment with an emulsion containing 0.1% micronised l-thyroxine.

2013-06-01

[G. Ital. Dermatol. Venereol. 148(3) , 287-92, (2013)]

[Efficacy of the anti-edema drug L-lysine aescinat in stroke].

2012-01-01

[Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 112(12 Pt 2) , 31-4, (2012)]

More Articles...